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        Introduction 
  Entry into mitosis requires a dramatic reorganization of nuclear 
and cytoplasmic compartments. These changes are driven by 
the activity of CDK1 associated with mitotic cyclins, notably 
cyclin B (CycB;   Morgan, 2006  ). Activation of CDK1 requires 
suffi  cient levels of CycB and the removal of CDK1 inhibitory 
phosphorylation. CDK1 phosphorylation is controlled by con-
served kinases Wee1 and Myt1 and by the phosphatase Cdc25. 
The rapid onset of CDK1 activation at the end of G2 is driven 
by inactivation of Wee1 and activation of Cdc25. Active CDK1 
contributes to these changes in Wee1 and Cdc25 activity, thus 
establishing a positive feedback loop that drives cells into mito-
sis (  Ferrell, 2002  ;   Morgan, 2006  ). 
  In spite of these insights, little is known about the mecha-
nisms by which nuclear and cytoplasmic CDK1 activities are 
coordinated. Resolving this issue requires determining whether 
nuclear and cytoplasmic CDK1 pools are differentially regu-
lated. Support for a differential regulation comes from the fi  nd-
ing that subcellular localization of CycB plays a role in regulating 
CDK1 activity. In vertebrates, CycB is predominantly cytoplas-
mic at interphase because of Crm1-mediated nuclear exclusion 
( Hagting et al., 1998 ;  Yang et al., 1998 ). At prophase, CDK1 – CycB 
is activated in the cytoplasm before its entry into the nucleus 
(  De Souza et al., 2000  ;   Jackman et al., 2003  ), and the abrupt 
CDK1  –  CycB nuclear translocation is triggered by the phosphory-
lation of CycB on its cytoplasmic retention signal (  Ookata et al., 
1993  ;   Pines and Hunter, 1994  ;   Li et al., 1997  ;   Hagting et al., 
1999  ;   Takizawa and Morgan, 2000  ). 
  Controlling the subcellular localization of CycB may also 
be involved in checkpoint function. Un-replicated or damaged 
DNA results in the activation of the conserved S-phase check-
point kinase 1 (Chk1), which inhibits Cdc25 and activates Wee1 
(  Furnari et al., 1997  ;   Peng et al., 1997  ;   Sanchez et al., 1997  ;   Lee 
et al., 2001  ). Consequently, the S-phase checkpoint delays the 
cell cycle in interphase by Chk1-mediated inhibition of CDK1 
(  Walworth, 2001  ;   Melo and Toczyski, 2002  ). However, expression 
of CDK1 
AF  , a version of CDK1 lacking the phosphorylation 
  inhibitory sites, only partially bypasses the interphase arrest 
induced upon DNA damage (  Jin et al., 1996  ). This arrest is fully 
bypassed by coexpressing CDK1 
AF   and nuclear-targeted CycB 
(  Heald et al., 1993  ;   Jin et al., 1998  ). These studies imply that 
prevention of CycB nuclear localization is one of the mecha-
nisms by which the S-phase checkpoint delays nuclear entry 
into mitosis. Thus, the coordination of cytoplasmic and nuclear 
mitotic entry likely involves the control of CycB subcellular local-
ization as well as the CDK1 phosphorylation state. 
  The late syncytial nuclear cycles of the   Drosophila    mela-
nogaster   embryo are regulated by levels of CycB and S-phase 
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  To determine whether new rounds of CycB synthesis are 
required for each mitotic cycle, we investigated the effect of 
  injecting CycB after treatment with the protein synthesis inhibitor 
cycloheximide (CHX). Injection of CHX at metaphase induced 
a cytoplasmic and nuclear interphase arrest in the next cycle 
(  Fig. 1 C  , left). Exogenous CycB locally overcame the CHX-
  induced interphase arrest as indicated by NEB and rapid spindle 
formation (  Fig. 1 C  , right; and Video 1, available at http://www
.jcb.org/cgi/content/full/jcb.200801153/DC1). The data suggest 
that new rounds of CycB synthesis are necessary to drive the 
next mitotic cycle. We determined by single embryo Western 
that the amount of injected CycB was equivalent to the total 
level of endogenous CycB at metaphase of cycle 13. Taking into 
account the limited diffusion of the injected CycB, we estimate 
that the 65   μ  M of exogenous CycB at the center of the gradient 
was less than fi  vefold the level of endogenous CycB at mitosis 
(see Materials and methods). 
  Injection of CycB prematurely drives the 
cytoplasm into mitosis 
  We next determined whether injected CycB prematurely drives 
the cytoplasm into mitosis. We addressed this issue by examin-
ing the dynamics of three cytoplasmic proteins fused with GFP 
that undergo dramatic changes in subcellular distribution during 
the cortical cycles: nonmuscle myosin II regulatory light chain 
([RLC]; RLC-GFP;   Fig. 2, A and D  ;   Royou et al., 2004  ), moesin 
(GFP-moesin;   Fig. 2 B   and Video 2, available at http://www.jcb
.org/cgi/content/full/jcb.200801153/DC1;   Edwards et al., 1997  ), 
and Nuclear fallout (GFP-Nuf;   Fig. 2 C   and Video 3;   Riggs 
et al., 2007  ). 
  In all embryos, CycB was injected at the onset of cycle 13 
interphase. We monitored the timing of cytoplasmic marker 
dynamics and NEB in areas close to and distant from the site of 
injection. We will refer to these as injected and control areas, 
respectively. In control areas, RLC-GFP concentrated at the 
cortex throughout interphase and dispersed just before NEB. 
This dispersion occurred 12 min after the onset of interphase 
(  n   = 23, average deviation [AVD] = 1.8;   Fig. 2, A and D  ; and 
see Fig. S1 for quantifi  cation of the RLC-GFP signal, available 
at http://www.jcb.org/cgi/content/full/jcb.200801153/DC1). 
In CycB-injected areas, RLC-GFP dispersed prematurely, 4 min 
after interphase onset (  n   = 23, AVD = 1.8;   Fig. 2, A and D  , blue 
outlines). Interestingly, in both areas, RLC-GFP disappearance 
always preceded NEB (  Fig. 2, A and D  , orange outlines). A pre-
vious study has shown that RLC-GFP dispersion is driven by 
CDK1 activity (  Royou et al., 2002  ). Therefore, our results indi-
cate that high levels of CycB promote premature cytoplasmic as 
well as nuclear CDK1 activation. 
  GFP-moesin, a marker for F-actin, reorganizes from caps 
at interphase into furrows in mitosis (  Edwards et al., 1997  ). 
By focusing 5   μ  m below the plasma membrane, only furrows 
that have extended to this depth are visualized (  Fig. 2 B  ). 
In control and CycB-injected regions, F-actin furrows pro-
gressed to this depth at 11.5 min. and 3.5 min after injection, 
respectively (  Fig. 2 B  , blue outlines). These experiments indi-
cate that exogenous CycB drives premature reorganization of 
the actin cytoskeleton. 
checkpoint activity (  Edgar et al., 1994  ;   Fogarty et al., 1997  ;   Sibon 
et al., 1997  ;   Stiffl  er et al., 1999  ;   Price et al., 2000  ;   Stumpff 
et al., 2004  ;   Crest et al., 2007  ). These cycles provide an excel-
lent system to address the role of CycB subcellular localization 
in driving cytoplasmic and nuclear mitotic events during normal 
and S-phase checkpoint  –  activated conditions. We addressed this 
question by taking advantage of our ability to inject functional 
CycB in the syncytial embryo at precise times during the cell 
cycle and to monitor its effects on multiple cytoplasmic and nu-
clear events. Increasing the level of CycB during early inter-
phase of cycle 13 induces premature nuclear envelope breakdown 
(NEB) and the reorganization of the cytoskeleton. Upon activa-
tion of the S-phase checkpoint, increased levels of CycB drives 
cytoplasmic but not nuclear mitotic events. We demonstrate that 
the S-phase checkpoint protects the nucleus from active cyto-
plasmic CDK1  –  CycB via two distinct mechanisms involving 
Grapes(Chk1)-dependent control of CycB nuclear localization 
and Wee1-dependent inhibition of nuclear CDK1. 
  Results 
  Injection of CycB prematurely drives NEB 
and spindle assembly 
  We injected recombinant CycB N-terminal GST fusion protein 
into living   Drosophila   embryos at precise times during inter-
phase of the syncytial cycle 13. GST-CycB is able to induce 
CDK1 phosphorylation on T161 and promote its kinase activity 
in vitro (  Edgar et al., 1994  ). We will refer to the recombinant 
protein as CycB. 
  Nuclear CDK1 activity is thought to promote chromosome 
condensation and NEB (  Lamb et al., 1990  ;   Peter et al., 1990  ; 
  Enoch et al., 1991  ). Therefore, nuclear mitotic events were de-
fi  ned by chromosome condensation (monitored with GFP-H2Av) 
and NEB (monitored by nuclear infusion of injected rhodamine-
conjugated tubulin). The central regions of embryos were injected 
with either 71   μ  M GST or 65   μ  M CycB at the onset of interphase 
of nuclear cycle 13. After GST injection, NEB occurred almost 
synchronously throughout the embryo at 14.3 min after injection, 
and the chromosomes entered anaphase shortly after NEB (  Fig. 
1 A  , GST). After CycB injection, the timing of NEB was greatly 
accelerated near the site of injection compared with NEB in areas 
more distant from the site of injection (  Fig. 1 A  , CycB, white out-
lines). Premature NEB occurs as a wave probably caused by the 
slow diffusion of CycB from the injection site. These observa-
tions indicate that CycB injection at 65   μ  M is suffi  cient to induce 
a local activation of CDK1, which triggers premature NEB and 
spindle assembly. This result is consistent with work  demonstrating 
that exogenous CycB promotes premature disassembly of the nu-
clear pore complex in syncytial   Drosophila   embryos (  Onischenko 
et al., 2005  ). Although CycB induced premature NEB, it did 
not promote premature chromosome condensation before NEB. 
At NEB, the level of chromosome condensation was much greater 
in the control embryo than in the CycB-injected embryo (  Fig. 1 B  , 
top row). In most cases, once NEB occurred in the area near the 
site of CycB injection, the chromosomes rapidly condensed and, 
by metaphase, achieved the same state of condensation as control 
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raises the possibility that cytoplasmic and nuclear CDK1 activ-
ities are differentially regulated by CycB levels. To explore this 
possibility, we monitored nuclear (NEB) and cytoplasmic (myosin 
dispersion) mitotic events after injecting CycB at a lower concen-
tration of 32   μ  M (  Fig. 2 D  ). In six out of eight injected embryos, 
32-  μ  M CycB dilution induced cytoplasmic and nuclear CDK1 
activation at a similar rate as 65   μ  M CycB. However, in two em-
bryos, although CycB induced premature myosin dispersion, it 
did not induce premature NEB (  Fig. 2 D  ). This uncoupling be-
tween the cytoplasmic and nuclear CDK1 activation rate suggests 
that different mechanisms regulate these two activities. 
  To further examine independent activation of cytoplasmic 
and nuclear CDK1, we took advantage of the prolonged inter-
phase of nuclear cycle 14. During this cycle, the nuclei arrest in 
interphase while the cytoskeleton reorganizes to form furrows 
that elongate and encompass each nucleus in a process known 
 To  confi  rm that the effect of CycB was not confi  ned to 
actin and myosin, we monitored the effect of CycB injection 
on Nuf, a Rab11 effector that exhibits a cell cycle  –  dependent 
association with the microtubule- organizing center (MTOC; 
  Fig. 2 C  ;   Riggs et al., 2003;     Cao et al., 2008  ). We fi  nd that GFP-
Nuf is concentrated at the MTOC through interphase of cycle 13 
in the control area. Upon CycB injection, Nuf prematurely 
disperses from the MTOC (  Fig. 2 C  , blue outlines). Collec-
tively, these observations indicate that high levels of CycB in-
duce local cytoplasmic CDK1 activation and trigger remodeling 
of the cytoskeleton. 
  CycB drives cytoplasmic events 
independently of the nuclear cycle 
  In the aforementioned studies, we observed that cytoplasmic 
mitotic events precede nuclear mitotic events. This observation 
  Figure 1.       CycB drives premature NEB and overrides CHX-induced interphase arrest.   (A) Injection of CycB induces premature NEB. GFP-H2Av (cyan) em-
bryos were injected with rhodamine-tubulin (red) and with either GST or CycB at the onset of cycle 13 interphase. The schematic describes the injection and 
imaging sequence. Insets are enlarged images of the noninjected areas (white boxes) and the CycB-injected areas (blue boxes). The GST and CycB-injected 
embryos are representative of four injected embryos for each protein. The nuclear cell cycle stages of the noninjected and CycB-injected areas (white out-
lines) are indicated at the top left and the bottom of the images, respectively. NEB is detected when rhodamine-tubulin invades the nucleoplasm (compare 
left inset with right inset, second row). Time is given in minutes/seconds. Arrowheads mark the site of injection. Bars, 20   μ  m. (B) Injection of CycB does 
not promote premature chromosome condensation before NEB. GFP-H2Av (cyan) embryos were injected with rhodamine-tubulin (red) followed by GST or 
CycB injection at the beginning of cycle 13 interphase. The top two rows show the state of chromosome condensation at NEB, which was determined by 
the nucleoplasm being ﬁ  lled with rhodamine-tubulin. The bottom two rows show the state of chromosome condensation at metaphase. Bars, 5   μ  m. 
(C) CycB injections overcome the CHX-induced cytoplasmic and nuclear interphase arrest. GFP-H2Av (cyan) embryos were injected with rhodamine-tubulin 
(red) followed by CHX at mitosis. GST or CycB was injected at the onset of the following interphase. The schematic describes the injection and imaging 
sequence. Arrowheads mark the site of injection. CycB induced NEB, chromosome condensation, and mitotic spindle formation (white outlines; see Video 1, 
available at http://www.jcb.org/cgi/content/full/jcb.200801153/DC1). The areas outlined in gray in the third row are enlarged in the bottom row. 
Time is given in minutes/seconds. Bars, 20   μ  m. (D) Single embryo Western blot of uninjected and CycB-injected embryos arrested at mitosis of cycle 13 
with colchicine. Anti-CycB antibodies were used to detect endogenous and injected CycB. Anti-GFP was used to detect a marker for loading controls. 
The injected embryo extract reveals an additional 78-kD molecular mass GST-CycB band.     JCB • VOLUME 183 • NUMBER 1 • 2008  66 
at http://www.jcb.org/cgi/content/full/jcb.200801153/DC1). 
However, the timing of NEB was not coordinated with the timing 
of myosin dispersion. Although CycB injection induced myosin 
dispersion promptly (4.6   ±   0.6,   n   = 5;   Fig. 3, A and C  ), NEB 
was delayed and occurred 5.5 min after myosin had dispersed 
(10.1   ±   2.1,   n   = 5;   Fig. 3, A and C  ). This uncoupling between 
the cytoplasmic and nuclear cycle was even more dramatic 
when CycB was injected 6  –  9 min after the onset of cellulariza-
tion. Injection of CycB at this later time failed to induce NEB 
(  Fig. 3, B and C  ), yet the cytoplasm entered mitosis rapidly 
after CycB injection (  Fig. 3, B and C, blue outlines  ; and Fig. S2). 
CycB also induced the reorganization of GFP-moesin into 
as cellularization. The mechanisms that trigger cellularization 
are not understood. To determine whether CycB is limiting for 
driving CDK1 activation at cycle 14, we injected CycB at differ-
ent times during cellularization and monitored cytoplasmic and 
nuclear CDK1 activation. Cytoplasmic CDK1 activation was 
monitored by examining RLC-GFP, GFP-moesin, and GFP-Nuf 
dynamics (  Fig. 3  ). Nuclear CDK1 activity was measured by 
monitoring NEB (when the cytoplasmic markers invade the 
nucleoplasm). When injected early during cellularization (3  –  5 min 
after nuclear envelope formation [NEF]), CycB triggered both 
cytoplasmic and nuclear entry into mitosis (  Fig. 3, A and C, 
blue and orange outlines, respectively  ; and Video 4, available 
  Figure 2.       CycB triggers reorganization of the 
cytoskeleton.   (A  –  C) RLC-GFP (A), GFP-moesin 
(B; see Video 2, available at http://www.jcb
.org/cgi/content/full/jcb.200801153/DC1), 
and GFP-Nuf (C; see Video 3) embryos were in-
jected with CycB at early interphase of cycle 13. 
The schematic describes the injection and 
imaging sequence. The timing of CycB injec-
tion in GFP-Nuf was performed at a time when 
Nuf was concentrated at the MTOC (midinter-
phase). Arrowheads mark the sites of injec-
tion. Top row insets are enlarged images of 
the control area, which is distant from the site 
of injection (white boxes), and bottom row in-
sets are enlarged images of the CycB-injected 
area (blue boxes). The RLC-GFP, GFP-moesin, 
and GFP-Nuf embryos are representative of 
15, 4, and 3 injected embryos, respectively. 
NEB is determined when the GFP markers ﬁ  ll 
the nucleoplasm. The blue and orange outlines 
mark the areas where CycB has an effect on 
the cytoplasm and the nucleus, respectively. 
Time is given in minutes/seconds. Bars: (pan-
els) 20   μ  m; (insets) 10   μ  m. (D) The timing of 
cytoplasmic and nuclear CDK1 activation 
after CycB injection was monitored with RLC-
GFP embryos. CycB was injected at 65 or 
32   μ  M at interphase onset, and the embryo was 
examined within 30 s after injection. The tim-
ing of cytoplasmic CDK1 activation was de-
termined when RLC-GFP disappeared from the 
focal plane. The timing of nuclear CDK1 ac-
tivation was determined when RLC-GFP ﬁ  lled 
the nucleoplasm (NEB). For each embryo, we 
monitored the timing of cytoplasmic and nu-
clear CDK1 activation in control and injected 
areas. Data are represented as mean   ±   AVD. 
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mutants and normal embryos, we injected the embryos simulta-
neously with CHX and Aph. This provides time to perform the 
injections in the exceedingly short cell cycles of the checkpoint-
compromised embryos. In wild-type embryos, the results are 
the same for injecting Aph alone or a combined injection of Aph 
and CHX (unpublished data). For both a wild-type and a   grp  
mutant, only the combined injections are described. 
  In all experiments presented in   Fig. 4  , CHX and Aph were 
injected together at mitosis of cycle 12 in embryos expressing 
RLC-GFP, which allowed us to simultaneously monitor cyto-
plasmic CDK1 activity (myosin dispersion) and nuclear CDK1 
activity (NEB). We injected CycB at two different time points 
during the next interphase, as represented by the schematic in 
  Fig. 4  . We injected CycB at the onset of interphase (early injec-
tion) and 10 min later (late injection). Injection of CycB during 
early interphase overcame the CHX + Aph  –  induced interphase 
arrest (  Fig. 4 A  ). The timing of cytoplasmic and nuclear CDK1 
activation was similar to embryos in which only CycB was in-
jected (  Fig. 4 D  ). The results were strikingly different when 
CycB was injected 10 min after the onset of interphase. NEB 
occurred in only 3 out of 15 embryos (  Fig. 4, B and D  ; and 
Fig. S1). Furthermore, NEB was delayed relative to the timing 
of cytoplasmic CDK1 activation (9.7   ±   1.9 min vs. 3.8   ±   0.2 min, 
  n   = 3). CDK1 was activated in the cytoplasm but not in the 
nucleus in 7 out of 15 embryos (  Fig. 4, B     and D  ; and Fig. S1). 
  furrows and the dispersion of Nuf from the MTOC (  Fig. 3 B, 
blue outlines;   and Video 5). However, there were no cases in 
which NEB occurred. CycB injected 15 min after the onset of 
cellularization had no effect on the progression of nuclear 
or   cytoplasmic events (  n   = 6; unpublished data). These experi-
ments show that increasing the level of CycB is suffi  cient to in-
duce an additional syncytial cycle. They demonstrate that CycB 
remains limiting for cytoplasmic and, to a lesser extent, nuclear 
CDK1 activation during early cellularization. Furthermore, they 
provide evidence that CDK1 can be activated in the cytoplasm 
independently of its activation in the nucleus. 
  The Grapes (Grp)-dependent S-phase 
checkpoint protects the nucleus from 
cytoplasmic CDK1 activity 
 We next addressed the effects of the S-phase checkpoint activity on 
cytoplasmic and nuclear CDK1 activation. To do so, we observed 
the effects of CycB injections in syncytial embryos arrested in 
interphase by injecting the DNA replication inhibitor aphidicolin 
(Aph). When Aph is injected during mitosis of cycle 12, it activates 
the S-phase checkpoint and induces a prolonged cytoplasmic and 
nuclear interphase arrest at the next cycle (unpublished data). 
  We next addressed whether CycB can overcome the 
S-phase checkpoint  –  induced cytoplasmic and nuclear interphase 
arrest. To perform this analysis in checkpoint-compromised 
  Figure 3.       CycB drives cytoplasmic mitotic 
events independently of the nuclear cycle 
during cellularization.   (A) CycB is limiting for 
nuclear and cytoplasmic CDK1 activity when 
injected at the onset of cycle 14 interphase. 
An RLC-GFP embryo was injected with CycB 
at cycle 14, 3 min after NEF. The arrowhead 
marks the site of injection. At the site of injec-
tion, RLC-GFP disappeared from the cortex 
5 min after injection (blue outlines). NEB oc-
curred 5 min later (orange outline; see Video 4, 
available at http://www.jcb.org/cgi/content/
full/jcb.200801153/DC1). Time is given in 
minutes/seconds. Bar, 20   μ  m. (B) CycB drives 
the cytoplasm but not the nuclei into mitosis 
when injected later during interphase of cycle 
14. RLC-GFP, GFP-moesin (see Video 5), and 
GFP-Nuf embryos were injected with CycB at 
cycle 14, 8 min after NEF. Arrowheads mark 
the sites of injection, and blue outlines mark 
the areas where the cytoplasm entered mitosis. 
Time is given in minutes/seconds. Bars, 20   μ  m. 
(C) The timing of cytoplasmic and nuclear 
CDK1 activation was determined as described in 
  Fig. 2  . Data are represented as mean   ±   AVD. 
n, number of embryos injected.     JCB • VOLUME 183 • NUMBER 1 • 2008  68 
sistent premature cytoplasmic and nuclear entry into mitosis at 
the site of injection (  Fig. 4, C and D  ). 
  These results support our previous conclusion that cyto-
plasmic CDK1 activity is independent of its activity in the 
nucleus. In addition, they suggest that the S-phase checkpoint 
is more effective at inhibiting CDK1 in the nucleus than in 
the cytoplasm. 
  CycB has a dynamic localization 
through the syncytial cycle and associates 
with kinetochores before NEB and 
during mitosis 
  Given that the nucleus can be protected from active cytoplasmic 
CDK1  –  CycB by the Grp-dependent S-phase checkpoint, this 
raises the possibility that the checkpoint operates by regulating 
CycB nuclear import (  Jin et al., 1998  ). To pursue this idea, we 
Finally, in 5 out of 15 embryos, neither cytoplasmic nor nuclear 
CDK1 activity was detected (  Fig. 4 B    ). 
  An explanation for the different results upon early and late 
injection of CycB into CHX + Aph  –  arrested embryos is that the 
S-phase checkpoint is activated in late but not in early injected 
embryos. We propose this idea because live analysis using a 
Grp-GFP fusion protein reveals that Grp is dispersed in the 
cytoplasm during mitosis and accumulates in the nucleus upon 
NEF (Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200801153/DC1). Thus, suffi  cient time after NEF is re-
quired to establish a functional S-phase checkpoint. To test this 
hypothesis, we performed the same experiments in the S-phase 
checkpoint – compromised  mutant   grp   (  Fig. 4 C  ). As with wild-
type embryos, CHX + Aph arrested the nuclei and cytoplasm 
of   grp   embryos in interphase (unpublished data). In contrast to 
wild type, CycB injected late into   grp   embryos triggered con-
  Figure 4.       CycB injections overcome the S-phase checkpoint  –  induced cytoplasmic cell cycle arrest, and to a lesser extent, nuclear cell cycle arrest.   (A  –  C) 
Wild-type (WT, A  –  B    ) or   grp   mutant embryos (C) expressing RLC-GFP were injected with CHX and Aph together (CHX + Aph) at metaphase of cycle 12. 
The embryos were injected with CycB at the onset of interphase (A, early CycB injection) or 10 min after the onset of interphase (B  –  C, late CycB injection). 
The schematic describes the injection and imaging sequence. Arrowheads mark the sites of injection. Blue outlines mark areas with cytoplasmic CDK1 
activity, and orange outlines mark areas where NEB occurs. Time is given in minutes/seconds. Bars, 20   μ  m. (D) Timing of cytoplasmic and nuclear CDK1 
activation was measured as described in   Fig. 2  . Data are represented as mean   ±   AVD. n, number of embryos injected.     69 COORDINATION OF CYTOPLASMIC AND NUCLEAR MITOTIC ENTRY   • Royou et al. 
we injected CycB-R after CHX + Aph treatment into wild-
type and   grp   mutant embryos expressing RLC-GFP (  Fig. 6  ). 
We assayed three different CycB-R concentrations (100, 56, 
and 13   μ  M). We monitored the induction of cytoplasmic and 
nuclear CDK1 activity by observing cortical myosin dispersion 
and NEB, respectively. We also monitored the timing of nuclear 
CycB-R localization. Embryos were injected with CHX + Aph 
in mitosis of cycle 12 followed by injection of CycB-R 10 min 
after the onset of cycle 13 interphase (  Fig. 6  , schematic). 
In wild-type embryos injected with 100   μ  M CycB-R, the cyto-
plasm entered mitosis, as indicated by the disappearance of 
the RLC-GFP signal from the cortex (  Fig. 6, A and F  , blue out-
lines; Fig. S1; and Video 6, available at http://www.jcb.org/cgi/ 
content/full/jcb.200801153/DC1). However, up to 15 min after 
CycB-R injection, we did not observe NEB or CycB-R localiza-
tion in the nucleus (  Fig. 6, A and F  ; and Video 6). In contrast, 
the same injection in   grp   mutant embryos provoked a rapid 
CycB-R nuclear import concomitant with cytoplasmic entry 
into mitosis (  Fig. 6, B and F  , blue outlines; and Video 7) and 
was immediately followed by NEB (  Fig. 6, B and F  , orange out-
lines; and Video 7). 
  Injection of 56 or 13   μ  M CycB-R into wild-type embryos 
previously treated with CHX + Aph did not trigger cytoplasmic 
and nuclear entry into mitosis for up to 15 min (  Fig. 6, C, G, 
and H  ). The fi  rst sign of CycB-R in nuclei (appearance of CycB-R 
puncta in at least three nuclei) was detected at a mean of 8.9 min 
for both CycB-R concentrations (  Fig. 6, C and I  , red arrow). 
Once in the nucleus, the CycB-R signal at the kinetochore in-
creased progressively. This observation rules out the possibility 
that the S-phase checkpoint is preventing CycB nuclear accu-
mulation by increasing the rate of nuclear CycB degradation 
(  Fig. 6 C  , compare the second row with the third row). In contrast, 
injection of 56 or 13   μ  M CycB-R in the   grp   mutant triggered 
analyzed the subcellular localization of CycB in living embryos 
by injecting rhodamine-labeled CycB (CycB-R). 
  We injected a low concentration of 13   μ  M CycB-R at the 
onset of interphase of cycles 12 and 13 in embryos expressing 
RLC-GFP (  Fig. 5 A  ), the kinase Polo fused with GFP (GFP-Polo; 
  Fig. 5 B  ;   Moutinho-Santos et al., 1999  ), or the centromere-
associated protein Cid fused with GFP (GFP-Cid;   Fig. 5 C  ;   Schuh 
et al., 2007  ). At this concentration, CycB-R did not induce prema-
ture entry into mitosis in fi  ve out of six wild-type embryos. CycB-R 
accumulates at the centrosome and is excluded from the nucleus 
during interphase, in agreement with our previous observations 
(  Huang and Raff, 1999  ). During early prophase, before NEB, 
CycB-R maintains its association with the centrosome and accu-
mulates in discrete puncta within the nucleus, indicating that the 
recombinant CycB used in these experiments is effi  ciently im-
ported into the nucleus (  Fig. 5 A  , arrows). After NEB, CycB-R is 
primarily associated with the bipolar spindle, consistent with ob-
servations in other cell types (  Pines and Hunter, 1991  ;   Yang et al., 
1998  ). In addition, a strong signal was also detected on the meta-
phase plate (  Fig. 5  ). CycB-R colocalized with kinetochore GFP-
Polo before NEB and throughout mitosis (  Fig. 5 B  , arrows). 
The CycB-R puncta in the nucleus before NEB colocalized with 
GFP-Cid (  Fig. 5 C  , arrows). This colocalization is observed during 
mitosis until late anaphase. Collectively, these observations suggest 
an association of CycB-R with the kinetochore that is initiated be-
fore NEB. The specifi  c localization of CycB-R into kinetochores 
before NEB provides a means to monitor CycB nuclear import. 
  The S-phase checkpoint prevents CycB 
nuclear accumulation by maintaining CDK1 
in an inactive state 
  To determine whether the S-phase checkpoint prevents nuclear 
CDK1 activation by controlling CycB subcellular localization, 
  Figure 5.       CycB localizes to the kinetochores before NEB.   RLC-GFP (A, cyan), GFP-Polo (B, cyan), and GFP-Cid (C, cyan) embryos were injected with 
13   μ  M CycB-R (red) at interphase of cycle 12 (A) or 13 (B and C). Arrows highlight the punctate nuclear localization of CycB-R (A) and its colocalization 
with GFP-Polo (B) and GFP-Cid (C) before NEB. Time is given in minutes/seconds. Bars, 5   μ  m.     JCB • VOLUME 183 • NUMBER 1 • 2008  70 
a CDK1 inhibitor (  Lee et al., 2001  ). Moreover, in mammalian 
cultured cells, Wee1 can protect the nucleus from active cyto-
plasmic CDK1 (  Heald et al., 1993  ). 
  To test whether a threshold of nuclear CDK1 activity is 
required to promote CycB nuclear accumulation, we performed 
the same experiment as described in the previous paragraph 
in   wee1   mutant embryos. We monitored the accumulation of 
CycB-R in the nucleus and its effect on cytoplasmic and nuclear 
CDK1 activation. The injection of CHX + Aph during the previous 
mitosis induced an interphase arrest for at least 10 min in a   wee1   
background. Injection of 100, 56, or 13   μ  M CycB-R provoked a 
rapid cytoplasmic and nuclear CDK1 activation (  Fig. 6, E  –  H  , 
cytoplasmic and nuclear entry into mitosis (  Fig. 6, D, H, and I  , 
blue and orange outlines, respectively). The fi  rst sign of CycB-R 
nuclear accumulation before NEB was detected at 2.2 min and 
3.7 min after injection of 56   μ  M and 13   μ  M CycB-R, respec-
tively (  Fig. 6, D and I  , red arrow). 
  These data indicate that the Grp S-phase checkpoint pre-
vents mitotic entry by delaying nuclear CycB accumulation. 
It may be that a threshold of nuclear CDK1 activity is required 
to trigger CycB import. Activation of the S-phase checkpoint 
may prevent nuclear CDK1 from reaching this threshold. Sup-
port for this idea comes from experiments in   Xenopus laevis , 
demonstrating that Chk1 phosphorylates and activates Wee1, 
  Figure 6.       The S-phase checkpoint delays nuclear CycB accumulation and CDK1 activation by a Grp and Wee1-dependent mechanism.   (A  –  E) Wild-type 
(A and C),   grp   (B and D), and   wee1   (E) embryos expressing RLC-GFP (cyan) were injected with a mix of Aph and CHX (CHX + Aph) at metaphase of cycle 12. 
10 min after the onset of the next interphase, they were injected with CycB-R (red) at the speciﬁ  ed concentrations. The schematic describes the injection 
and imaging sequence. Time is given in minutes/seconds (see Videos 6, 7, and 8 for A, B, and E, respectively, available at http://www.jcb.org/cgi/
content/full/jcb.200801153/DC1). The right column of each panel is an enlargement of the area outlined with the white box shown on the ﬁ  rst image of 
the left column. However, for A and B, the areas are at a focal plane 2   μ  m above the focal plane shown in the left columns. Blue outlines mark the areas 
with cytoplasmic CDK1 activity, and orange outlines mark the areas undergoing NEB. (C and D) Red arrows point to the nuclear localization of CycB-R. 
n, number of embryos injected. Bars: (left columns) 20   μ  m; (right columns) 5   μ  m. (F  –  H) 100 (F), 56 (G), and 13   μ  M (H) CycB-R was injected 10 min after 
the onset of interphase in CHX + Aph  –  treated embryos. The timing of cytoplasmic and nuclear CDK1 activation was determined as described in   Fig. 2  . 
(I) The timing of CycB-R accumulation in nuclei was determined when CycB-R appeared at kinetochores in at least three nuclei. (F  –  I) Data are represented 
as mean   ±   AVD. n, number of embryos injected.     71 COORDINATION OF CYTOPLASMIC AND NUCLEAR MITOTIC ENTRY   • Royou et al. 
2006  ) and Roscovitine (  Meijer et al., 1997  ). We performed 
the same experiments as described in   Fig. 6  , monitoring CycB 
nuclear import in wild-type,   grp  , and   wee1   embryos but with 
CDK1 maintained inactive through injection of CDK1 inhibi-
tors (  Fig. 7  ). In   grp   and   wee1   mutant embryos treated with 
CHX + Aph, CycB-R triggered rapid myosin dispersion from 
the cortex and NEB (  Fig. 6, D  –  H  ). In contrast, the addition of 
Roscovitine or RO-3306 before CycB-R injection prevented 
both myosin dispersion and NEB ( Fig. 7, B and C ). This demon-
strates that these compounds effi  ciently inhibit cytoplasmic and 
nuclear CDK1 activity. 
  In wild-type embryos treated with CHX + Aph and RO-
3306, no nuclear CycB-R signal was detected in three out of 
seven embryos for up to 15 min. The fi  rst signs of CycB-R in 
the nuclei were detected at a mean of 12.9 min (  n   = 7;   Fig. 7 D  ). 
A similar result was obtained with Roscovitine; no nuclear 
CycB-R signal was detected in 5 out of 10 embryos for up to 
15 min (unpublished data). In the other fi  ve injected embryos, 
CycB-R started accumulating in the nucleus at a mean of 12.2 min 
(  Fig. 7, A and D  ). In   grp   mutant embryos injected with CHX + 
blue and orange outlines, respectively; and Video 8, available 
at http://www.jcb.org/cgi/content/full/jcb.200801153/DC1). 
In each experiment, CycB-R nuclear import always occurred 
  <  3 min after injection (  Fig. 6 I  ). 
  Collectively, these data reveal that high nuclear CDK1 ac-
tivity correlates with rapid CycB nuclear import, and low nu-
clear CDK1 activity correlates with delayed CycB nuclear 
import (  Fig. 7 E  ). The S-phase checkpoint, acting through Grp 
and Wee1, inhibits nuclear CDK1 activity and prevents CycB 
nuclear accumulation. 
  Grp also delays CycB nuclear accumulation 
via a mechanism independent of Wee1 and 
the state of nuclear CDK1 activity 
  To determine whether the S-phase checkpoint infl  uences CycB 
nuclear import independently of the state of nuclear CDK1 
activity, we monitored CycB-R dynamics in wild-type,   grp ,   
and   wee1   mutant embryos under conditions in which CDK1 is 
maintained inactive. This was achieved through injecting dis-
tinct, small molecule CDK1 inhibitors RO-3306 (  Vassilev et al., 
  Figure 7.       Grp prevents CycB nuclear accumulation by a Wee1-independent mechanism.   (A  –  C) Wild-type (A),   grp   (B), and   wee1   (C) mutant embryos ex-
pressing RLC-GFP (cyan) were injected with a mix of Aph and CHX (CHX + Aph) at metaphase of cycle 12. 5  –  8 min after the onset of the next interphase, 
they were injected with 10 mM of the CDK1 inhibitor Roscovitine followed by 13   μ  M CycB-R (see Videos 9 and 10 for B and C, available at http://www
.jcb.org/cgi/content/full/jcb.200801153/DC1). The schematic describes the injection and imaging sequence. The right column of each panel is an en-
largement of the area outlined by the white box in the ﬁ  rst images of the left column. Red arrows point to the nuclear localization of CycB-R. Time is given 
in minutes/seconds. Bars: (left) 20   μ  m; (right) 5   μ  m. (D) Histograms indicate the time until CycB-R starts accumulating in at least three nuclei in embryos 
treated with CHX + Aph and the CDK1 inhibitors Roscovitine or RO-3306. The embryos injected with RO-3306 and Roscovitine were subsequently injected 
with 56   μ  M and 13   μ  M, respectively. Data are represented as mean   ±   AVD. n, number of embryos injected. *, only 5 out of 10 wild-type embryos injected 
with Roscovitine showed nuclear CycB-R accumulation before 15 min, which is the time limit of each video for the Roscovitine assay. Therefore, the mean 
timing of nuclear CycB-R import represents only half of the embryos injected. (E) The table summarizes the results in   Figs. 6 and 7  . (F) The schematic pre-
sents a model for the control of CycB nuclear import. CycB nuclear accumulation is inhibited by Grp and activated by nuclear CDK1 activity, which is itself 
inhibited by Grp and Wee1.     JCB • VOLUME 183 • NUMBER 1 • 2008  72 
knockdown of the three mitotic cyclins with RNAi blocks the 
syncytial cycles but does not affect the timing of cellularization 
(  McCleland and O  ’  Farrell, 2008  ). Both fi  ndings are compat-
ible with the idea that low levels of CycB are required for the 
correct timing of cellularization. Earlier work demonstrated 
that inhibition of zygotic transcription also prevents cellu-
larization and drives an additional round of syncytial mitosis 
(  Edgar et al., 1986  ). Collectively, these results fi  t a model in 
which cellularization is triggered by thresholds of high lev-
els of as yet unknown zygotic gene products and low levels 
of CycB. Although injecting CycB within the fi  rst 9 min of 
cycle 14 prevents cellularization, injecting CycB after this 
time point has no effect on cellularization. This suggests a nar-
row time window in which the embryo is not fully committed 
to cellularization. 
  CycB injections uncouple the cytoplasmic 
and nuclear cycles 
  Our results also demonstrate that CDK1 can be activated in the 
cytoplasm independent of its activation in the nucleus. The pro-
longed interphase of nuclear cycle 14 provided us with an op-
portunity to determine the effects of CycB injections later in 
interphase. Early injections of CycB (0  –  5 min after NEF) pre-
maturely drive nuclear and cytoplasmic events. However, CycB 
injections later in interphase (6  –  9 min after NEF) drive the 
cytoplasm but not the nuclei into mitosis. Specifi  cally, we ob-
serve myosin dispersion while the nuclear envelope remains in-
tact. Given that myosin dispersion requires high CDK1 activity 
(  Royou et al., 2002  ), these studies indicate that CDK1 is acti-
vated in the cytoplasm but not in the nucleus. This result is con-
sistent with the observation that the cytoplasm continues to 
cycle in enucleated frog embryos ( Wasserman and Smith, 1978 ). 
It is also in accord with studies in mammalian cultured cells and 
  Xenopus   egg extracts, indicating that the CDK1  –  CycB complex 
is activated in the cytoplasm before its nuclear activation (  Heald 
et al., 1993  ;   Jin et al., 1996  ;   De Souza et al., 2000  ;   Draviam et al., 
2001  ;   Jackman et al., 2003  ). 
  The S-phase checkpoint component Grp 
prevents nuclear CDK1 activation 
  In performing CycB injection in embryos treated with Aph 
and CHX, we observed that the effects of CycB on nuclear and 
cytoplasmic CDK1 activation varied depending on the timing 
of injection. CycB injections during early interphase drive both 
cytoplasmic and nuclear CDK1 activation, whereas later injec-
tions induced only cytoplasmic CDK1 activation. Moreover, this 
nuclear protection from premature cytoplasmic CDK1 activity 
upon late CycB injection depends on the S-phase checkpoint 
component Grp. Our observation that Grp must be imported into 
the nucleus at the beginning of interphase raises the possibility 
that time is required for suffi  cient quantities of Grp to accu-
mulate in the nucleus and create a functional S-phase check-
point. Injection of CycB induces mitosis in both the nuclei and 
cytoplasm early in interphase because the S-phase checkpoint 
is not fully established. However, later in interphase, Grp has 
accumulated suffi  ciently in the nucleus to completely prohibit 
nuclear CDK1 activation. 
Aph and either RO-3306 or Roscovitine, no sign of cytoplasmic 
and nuclear CDK1 activity was observed. In contrast to wild-
type embryos, CycB-R rapidly accumulated in the nucleus in 
all injected embryos. The fi  rst signs of CycB-R in the nucleus 
were detected at a mean of 5.5 min and 5.8 min in Roscovitine- 
and RO-3306  –  injected embryos, respectively (  Fig. 7, B and D  ; 
and Video 9, available at http://www.jcb.org/cgi/content/full/
jcb.200801153/DC1). In contrast, in the   wee1   mutant, no nu-
clear CycB-R was detected in any Roscovitine- or RO-3306  – 
injected embryos for up to 15 min (  Fig. 7, C and D  ; and Video 10). 
These data reveal that in addition to its role in maintaining 
nuclear CDK1 in an inactive state, Grp prevents nuclear accu-
mulation of CycB through a separate mechanism not shared by 
Wee1 (  Fig. 7 F  ). 
  Discussion 
  Increased levels of CycB induce premature 
cytoplasmic and nuclear CDK1 activation 
  In this study, we directly address the role of CycB in driving the 
syncytial divisions in the   Drosophila   embryo by demonstrating 
that increased levels of CycB are suffi  cient to trigger nuclear and 
cytoplasmic mitotic entry. Unlike more conventional cell cycles, 
the maternal pool of CycB is not fully degraded during these 
syncytial mitotic divisions; therefore, it was not clear whether 
CycB was limiting for CDK1 activation (  Edgar et al., 1994  ). 
Our fi  nding that inhibition of protein synthesis induced a prolonged 
interphase in wild-type and S-phase checkpoint  –  compromised 
embryos indicates that new rounds of protein synthesis are 
required to drive the late syncytial cycles. Of more signifi  cance 
is the fact that injection of CycB into these interphase-arrested 
embryos effi  ciently drives cytoplasmic and nuclear entry into 
mitosis. Our data imply that, even though CycB is not fully de-
graded at mitosis, new rounds of CycB synthesis are required 
to trigger the next mitosis. Support for this idea comes from 
the fact that increasing the maternal copies of CycB affects the 
timing of entry into mitosis during the late syncytial cycles 
(  Ji et al., 2004  ). It may also be that the pool of endogenous 
CycB is maintained in a form that prevents CDK1 activation 
through posttranslational modifi  cations and that the exogenous 
CycB lacks these modifi  cations. 
  Careful analysis of the timing of cytoplasmic and nuclear 
mitotic events in the last syncytial cycle reveals that initiation of 
chromosome condensation and reorganization of the cytoskele-
ton occur before NEB. We have found that, even in the absence 
of protein synthesis, exogenous CycB can effi  ciently coordinate 
the reorganization of the cytoskeleton with NEB. However, ex-
ogenous CycB does not preserve the order of the nuclear mitotic 
events because the chromosomes did not condense before NEB. 
There are three maternal mitotic cyclins in a   Drosophila   em-
bryo, cyclin A, B, and B3, with overlapping functions (  Jacobs 
et al., 1998  ). One interesting idea is that the proper ratio of the 
three mitotic cyclins is required to maintain the order of the nu-
clear events. 
  We have observed that increased levels of CycB at the 
onset of cellularization during cycle 14 drive an additional 
round of syncytial mitosis. A recent study has shown that the 73 COORDINATION OF CYTOPLASMIC AND NUCLEAR MITOTIC ENTRY   • Royou et al. 
  Grp also delays CycB nuclear accumulation 
by a mechanism independent of Wee1 
 Signifi  cantly, our observation that Grp-mediated inhibition of 
CycB nuclear import is independent of both Wee1 and the state 
of nuclear CDK1 activity reveals an additional mechanism by 
which the S-phase checkpoint prevents nuclear CDK1 activation. 
Monitoring CycB nuclear import in Aph and CHX-treated wild-
type   wee1   and   grp   mutant embryos in which CDK1 is main-
tained in an inactive state reveals that CycB is rapidly imported 
into the nucleus only in the   grp   mutant.  These  results  indicate 
a novel mechanism by which the S-phase checkpoint prevents 
mitotic entry: a Grp-dependent but Wee1-independent mecha-
nism that prevents CycB nuclear accumulation. A satisfying 
  aspect of this result is that it readily explains why bypassing 
interphase arrest caused by DNA damage not only requires a 
constitutively active form of CDK1 but also nuclear localized 
CycB (  Jin et al., 1998  ). It would be of interest to determine 
whether Grp inhibits nuclear import of other cyclins as well. 
  The observation that CycB rapidly accumulates in the 
nucleus in the   wee1   mutant where Grp is fully active contrasts 
with our results that Grp delays CycB nuclear import. One idea 
is that, in the absence of   wee1  , the active form of nuclear CDK1 
associated with basal levels of CycB promotes CycB (and more 
likely the CDK1  –  CycB complex) nuclear import, which in turn 
increases nuclear CDK1 activity. This triggers a positive feed-
back loop that effi  ciently bypasses the Grp inhibitory signal. 
  Model for the regulation of cytoplasmic and 
nuclear CDK1 activity 
  This study provides a model to explain the differential regu-
lation of cytoplasmic and nuclear CDK1 in a normal cycle. 
We speculate that, at interphase, the slow rate of CycB synthesis 
in the cytoplasm provides suffi  cient time for cytoplasmic CDK1 
inhibitors, such as Wee1 and Myt1, to prevent cytoplasmic 
CDK1 activation (  Price et al., 2000  ;   Stumpff et al., 2004  ;   Jin 
et al., 2005  ). However, nuclear CDK1 inhibition is maintained 
by controlling CycB nuclear accumulation. At interphase, the 
rate of CycB nuclear translocation is low because of inhibition 
of nuclear CDK1 by Wee1 and Grp-dependent inhibition of 
CycB transport. Upon completion of S phase, Grp and Wee1 
activity decreases. This triggers cytoplasmic CDK1 activation 
and initiation of cytoplasmic mitosis. This decrease in Grp and 
Wee1 activity also allows the abrupt CycB nuclear translocation 
catalyzed by nuclear CDK1 activity, thus increasing CDK1 ac-
tivity to a level suffi  cient for triggering NEB. 
  Materials and methods 
    Drosophila   stocks 
  The ﬂ  y stocks GFP-H2Av (  Clarkson and Saint, 1999  ), GFP-moesin (  Edwards 
et al., 1997  ), RLC-GFP (  Royou et al., 2004  ), GFP-Nuf (  Riggs et al., 2007  ), 
GFP-Polo (  Moutinho-Santos et al., 1999  ), and GFP-Cid (  Schuh et al., 2007  ) 
were used in these studies. The   grp   embryos were derived from a female 
homozygote for the   grp 
1     null allele (  Fogarty et al., 1994  ). The   wee1   em-
bryos were derived from females carrying the null allele d  wee1 
ES1     over 
Df(2L)  dwee1 
wo5     deﬁ  ciency (  Price et al., 2000  ). 
  GFP-Grp cloning 
  GFP-Grp  –  bearing transgenics were constructed by ligating a full-length   grp   
cDNA into pEGFP-C3 (Clontech Laboratories, Inc.) upstream of the GFP 
  How does Grp protect the nucleus from active cytoplas-
mic CDK1? In response to damaged or incompletely replicated 
DNA, Chk1 phosphorylates Cdc25, altering its relative import/
export rates such that it remains cytoplasmic (  Furnari et al., 1997  ; 
  Peng et al., 1997  ;   Sanchez et al., 1997  ;   Takizawa and Morgan, 
2000  ). Additionally, Chk1 has been shown to phosphorylate and 
activate Wee1 (  Lee et al., 2001  ). Although these fi  ndings remain 
to be demonstrated in   Drosophila  , it provides an explanation for the 
Grp-dependent protection of the nucleus from active cytoplas-
mic CDK1. Grp maintains the inhibitory tyrosine phosphory-
lation on nuclear CDK1 via activation of Wee1 and exclusion 
of Cdc25 from the nucleus. Support for this idea comes from a 
study in mammalian cultured cells in which overexpession of 
Wee1 prevents NEB in the presence of high cytoplasmic CDK1 
activity (  Heald et al., 1993  ). The fact that increased levels of 
cytoplasmic CycB overrides the cytoplasmic but not the nuclear 
S-phase checkpoint inhibitory signal suggests that the S-phase 
checkpoint is more effi  cient at inhibiting CDK1 in the nucleus. 
One idea is that the level of S-phase checkpoint activity is higher 
in the nucleus than in the cytoplasm. This notion is supported 
by experiments in binucleate yeast and sea urchin embryos in 
which one of the two nuclei has altered DNA. Entry into mito-
sis is delayed in the nucleus with altered DNA with respect to 
the other normal nucleus and the common cytoplasm (  Sluder 
et al., 1995  ;   Demeter et al., 2000  ). In addition, our observa-
tions, as well as others  ’  , that Grp and Wee1 are predominantly 
nuclear during S phase support this idea (  Heald et al., 1993  ; 
  Purdy et al., 2005  ). 
  Grp and Wee1 delay CycB 
nuclear accumulation 
  The subcellular localization of CycB plays an important role 
in regulating nuclear CDK1 activity (  Takizawa and Morgan, 
2000 ).  Specifi  cally, it has been shown in mammalian cultured 
cells that CycB is predominantly cytoplasmic during the G2 
  arrest caused by DNA damage, and a nuclear-targeted CycB can 
partially bypass this arrest (  Smeets et al., 1994  ;   Jin et al., 1998  ). 
To test the hypothesis that the S-phase checkpoint affects CycB 
subcellular localization, we injected CycB-R and monitored its 
dynamics after inhibition of DNA replication in wild-type em-
bryos and embryos lacking Grp or Wee1. In a normal cycle, we 
observed that CycB-R is imported into the nucleus and forms 
discrete puncta, which colocalize with GFP-Polo and GFP-Cid, 
suggesting an association of CycB-R with kinetochores before 
NEB. This provides an excellent means to monitor CycB nu-
clear accumulation. 
  In embryos with high S-phase checkpoint activity, CycB 
nuclear accumulation was impaired. In contrast, in   grp   mutant 
embryos, CycB rapidly accumulated in the nucleus. One expla-
nation is that in the absence of Grp, Wee1 activity is low, result-
ing in high nuclear CDK1 activity, which in turn promotes CycB 
import. Consistent with this hypothesis, we also found that CycB-R 
is rapidly imported into the nucleus and promotes NEB in   wee1  
mutant embryos. Interestingly, the observation that high levels 
of CycB effi  ciently triggered cytoplasmic CDK1 activation but 
failed to localize in the nucleus reveals that cytoplasmic CDK1 
activity is not suffi  cient to promote CycB nuclear import. JCB • VOLUME 183 • NUMBER 1 • 2008  74 
until they reached interphase of cycle 13. They were injected with 0.5 mM 
colchicine and monitored until they reached metaphase. Each embryo was 
either collected and boiled in 10   μ  l of sample buffer or injected with 65   μ  M 
CycB and immediately collected and boiled in 10   μ  l of sample buffer. 
The samples were loaded on a 10% acrylamide gel and transferred onto 
the nylon membrane, and the membrane was probed with anti-CycB to re-
veal endogenous CycB and GST-CycB. Membranes were also probed with 
anti-GFP (Roche) to reveal RLC-GFP as a loading control. As expected, the 
injected embryo extract reveals an additional higher molecular weight 
GST-CycB band (  Fig. 1 D  , injected CycB). The intensities of the endog-
enous and injected CycB bands were estimated to be equivalent. Because 
CycB is injected at the center of the embryo lengthwise and diffuses very 
slowly through a ﬁ  fth of the embryo, we estimated that, at the center of the 
gradient, the injected CycB is   <  10-fold the amount of endogenous CycB at 
mitosis of cycle 13. 
  Online supplemental material 
  Fig. S1 shows RLC-GFP signal intensities over time in control and CycB-
injected areas of embryos previously injected or not injected with CHX 
and Aph. Fig. S2 shows a saggital view of an embryo expressing RLC-
GFP injected with CycB 8 min after the onset of cellularization. Fig. S3 
shows the dynamics of Grp-GFP from cycle 13 through cycle 14 in an 
embryo previously injected with rhodamine-tubulin. Video 1 corresponds 
to the embryo presented in   Fig. 1 C  . Video 2 corresponds to the embryo 
presented in   Fig. 2 B  . Video 3 corresponds to the embryo presented in 
  Fig. 2 C  . Video 4 corresponds to the embryo presented in   Fig. 3 A  . Video 5 
corresponds to the embryo presented in   Fig. 3 B  . Video 6 corresponds 
to the embryo presented in   Fig. 6 A  . Video 7 corresponds to the embryo 
presented in   Fig. 6 B  . Video 8 corresponds to the embryo presented 
in   Fig. 6 E  . Video 9 corresponds to the embryo presented in   Fig. 7 B  , 
where only CycB-R is visualized. Video 10 corresponds to the embryo 
presented in   Fig. 7 C  , where only CycB-R is visualized. Online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200801153/DC1. 
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  CycB puriﬁ  cation 
  Two independent GST-CycB puriﬁ   cations were performed and produced 
identical results. CycB cDNA was cloned at its N terminal to GST in pGEX-1 
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and rinsed with a 1-vol column with wash buffer without Tween 20. The pro-
tein was eluted with 50 mM Tris, pH 8.1, containing 500 mM KCl and 
5 mM of reduced glutathione. The fractions were pooled and dialyzed ex-
tensively into 50 mM Hepes, pH 7.6, 500 mM KCl, and 30% glycerol. 
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vitro (  Edgar et al., 1994  ). Another recent study has shown that GST-CycB is 
resistant to degradation in   Xenopus   embryo extracts (  Su et al., 1998  ). Our 
studies have focused on mitotic entry, not exit, so the fact that it is not de-
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  Microscopy 
  Microscopy was performed at RT with an inverted microscope (DMIRB; 
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